Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

So far there have been several variants of the virus -- B.1.1.7, B.1.351, P.1, Delta, B.1.617.2, BA.5. Omicron BF.7 strain is driving the current wave of Covid infections in China. As of now ...

The new vaccine is an updated version of Moderna's widely-use Spikevax vaccine, which includes sequences from the original Wuhan strain of SARS-CoV-2, as well as from the Omicron BA.1 subvariant.

4 and BA.5 lineages of the Omicron variant are currently causing ... after a disappointing phase 1/2 trial, ceding the ground to mRNA shots in development at Moderna and BioNTech.

The results of a head-to-head Phase 3 study demonstrated that KOSTAIVE maintained superior immunogenicity compared to the conventional mRNA vaccine COMIRNATY for up to one year against Wuhan-Hu-1 and ...

Over the last few years, the SARS-CoV-2 virus, responsible for COVID-19, has undergone significant changes, evolving from the ...

Researchers at Kumamoto University have made a significant breakthrough in the fight against COVID-19 with the development of ...

The XBB.1.5 subvariant — nicknamed ‘Kraken’ — is arguably the most genetically rich and most transmissible SARS-CoV-2 omicron subvariant yet. News Wrap: Russia shells Bakhmut in eastern ...